Who invested in Emergence Therapeutics?
2 investors are on record as having backed Emergence Therapeutics — Nectin-4 antibody-drug conjugate for solid tumours, in Biotech, Europe. Each row below says whether the round came from the investor's own portfolio page or from the press.
emergencetx.comEmergence Therapeutics investors
Hadean VenturesInvests in science-driven healthcare and life sciences, backing visionary founders…their site
Pontifax VCHealthcare-dedicated VC investing in groundbreaking life sciences innovations across all…their site
No round dates are on record for Emergence Therapeutics. A portfolio page names its companies far more often than it dates the cheque, and we would rather leave the field empty than guess it.
The funds that backed Emergence Therapeutics are in the directory.
If they wrote this cheque, they may write yours. Pitch2Fund scores your startup against every one of them, gives you the partner to write to, and drafts the email. Free.